Background: Recent studies show that erythropoietin (EPO) plays a protective role in brain
ischemia. In this condition, administration of EPO protects neurons from ischemic damage …

Objective Erythropoietin (EPO) is a hormone that is currently used to treat patients with renal
failure and anaemia. However, it has also been shown to protect against …

Erythropoietin (EPO), originally identified for its critical hormonal role in promoting
erythrocyte survival and differentiation, is a member of the large and diverse cytokine …

Erythropoietin (EPO) is a hormone known to stimulate hematopoiesis. However, recent
research suggests additional properties of EPO, such as protection against …

Erythropoietin (epo), initially recognized and used clinically to increase erythropoiesis, has
been shown to have beneficial effects on various other tissues in the setting of hypoxia and …

Objectives: We assessed the effects of erythropoietin (EPO) treatment in a rat model of post-
myocardial infarction (MI) heart failure. Background: Erythropoietin, traditionally known as a …

Erythropoietin (EPO) is a hypoxia-induced hormone produced in the kidneys that stimulates
hematopoiesis in the bone marrow. However, recent studies have also shown important …

Here we investigate the effects of erythropoietin (EPO) on the tissue/organ injury caused by
hemorrhagic shock (HS), endotoxic shock, and regional myocardial ischemia and …

Langendorff‐perfused rat hearts treated with EPO exhibited significantly improved
postischemic recovery of left ventricular developed pressure (LVDP) and reduced infarct …

Erythropoietin (Epo) was once thought to act exclusively in the formation of red blood cells.
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …